Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review. | Cancers (Basel) | 2023 | 37296950 | PubTator, text mining | PubMed |
| Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape. | Cancers (Basel) | 2023 | 37296916 | PubTator, text mining | PubMed |
| The molecular and clinical role of Tensin 1/2/3 in cancer. | J Cell Mol Med | 2023 | 37296531 | PubTator, text mining | PubMed |
| Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. | Med Oncol | 2023 | 37291277 | PubTator, text mining | PubMed |
| Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features. | Am J Surg Pathol | 2023 | 37288826 | PubTator, text mining | PubMed |
| Epigenetic markers and therapeutic targets for metastasis. | Cancer Metastasis Rev | 2023 | 37286865 | PubTator, text mining | PubMed |
| Primary Mucosal Melanoma of the Lip With GNA11 Mutation in a 23-Year-Old Pregnant Woman. | Cureus | 2023 | 37284406 | PubTator, text mining | PubMed |
| Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer. | Genes Genomics | 2023 | 37277571 | PubTator, text mining | PubMed |
| A novel exosome-derived prognostic signature and risk stratification for breast cancer based on multi-omics and systematic biological heterogeneity. | Comput Struct Biotechnol J | 2023 | 37273850 | PubTator, text mining | PubMed |
| Epigenetic targets in B- and T-cell lymphomas: latest developments. | Ther Adv Hematol | 2023 | 37273421 | PubTator, text mining | PubMed |
| SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients. | Discov Oncol | 2023 | 37273084 | PubTator, text mining | PubMed |
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers. | Clin Epigenetics | 2023 | 37270516 | PubTator, text mining | PubMed |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. | Thorac Cancer | 2023 | 37265111 | PubTator, text mining | PubMed |
| Clinical case report: mosaic ANK3 pathogenic variant in a patient with autism spectrum disorder and neurodevelopmental delay. | Cold Spring Harb Mol Case Stud | 2023 | 37263801 | PubTator, text mining | PubMed |
| MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer. | Elife | 2023 | 37261974 | PubTator, text mining | PubMed |
| Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer. | Oncoimmunology | 2023 | 37261085 | PubTator, text mining | PubMed |
| Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion. | Gastroenterology | 2023 | 37257519 | PubTator, text mining | PubMed |
| Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations. | J Clin Invest | 2023 | 37252797 | PubTator, text mining | PubMed |
| The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level. | Hemasphere | 2023 | 37251913 | PubTator, text mining | PubMed |
| The First Case of Cribriform-Morular Thyroid Carcinoma and FAP with APC Gene Mutation in China: A Case Report and Brief Review. | Case Rep Gastrointest Med | 2023 | 37251554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=31